{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T16:02:33Z","timestamp":1776873753707,"version":"3.51.2"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2019.00095","type":"journal-article","created":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T04:21:51Z","timestamp":1551414111000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Factors Predicting Time to TSH Normalization and Persistence of TSH Suppression After Total Thyroidectomy for Graves' Disease"],"prefix":"10.3389","volume":"10","author":[{"given":"Rosa Maria","family":"Paragliola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Di Donna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Locantore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampaolo","family":"Papi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Pontecorvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore Maria","family":"Corsello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1245\/s10434-014-4095-6","article-title":"Clinical and socioeconomic factors influence treatment decisions in Graves' disease","volume":"22","author":"Elfenbein","year":"2015","journal-title":"Ann Surg Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"R231","DOI":"10.1530\/EJE-17-0947","article-title":"Management of endocrine disease: pitfalls on the replacement therapy for primary and central hypothyroidism in adults","volume":"178","author":"de Carvalho","year":"2018","journal-title":"Eur J. Endocrinol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1089\/thy.2014.0111","article-title":"A new strategy to estimate levothyroxine requirement after total thyroidectomy for benign thyroid disease","volume":"24","author":"Di Donna","year":"2014","journal-title":"Thyroid."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.1210\/jc.2007-0287","article-title":"National health and nutrition examination survey III thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction","volume":"92","author":"Spencer","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"B5","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/cen.13344","article-title":"Delayed TSH recovery after dose adjustment during TSH-suppressive levothyroxine therapy of thyroid cancer","volume":"87","author":"Kim","year":"2017","journal-title":"Clin Endocrinol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0889-8529(05)70186-9","article-title":"Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease","volume":"30","author":"Ross","year":"2001","journal-title":"Endocrinol Metab Clin North Am."},{"key":"B7","doi-asserted-by":"publisher","first-page":"E31","DOI":"10.25011\/cim.v38i1.22574","article-title":"Thyroid stimulating hormone suppression post-therapy in patients with Graves' disease: a systematic review of pathophysiology and clinical data","volume":"38","author":"Yu","year":"2015","journal-title":"Clin Invest Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1365-2265.1982.tb03174.x","article-title":"Analysis of factors in hyperthyroidism, which determine the duration of suppressive treatment before recovery of thyroid stimulating hormone secretion","volume":"16","author":"Fischer","year":"1982","journal-title":"Clin Endocrinol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S0025-6196(12)60272-9","article-title":"The pituitary gland in hyperthyroidism","volume":"67","author":"Scheithauer","year":"1992","journal-title":"Mayo Clin Proc."},{"key":"B10","first-page":"501","article-title":"The participation of \u201cshort\u201d feedback mechanisms in the control of ACTH and TSH secretion","volume":"69","author":"Motta","year":"1969","journal-title":"Acta Neurol Psychiatr Belg."},{"key":"B11","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1089\/thy.2004.14.825","article-title":"Ultra short-loop feedback control of thyrotropin secretion","volume":"14","author":"Prummel","year":"2004","journal-title":"Thyroid."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1210\/jc.2003-030430","article-title":"Thyrotropin receptor autoantibodies are associated with continued thyrotropin suppression in treated euthyroid Graves' disease patients","volume":"88","author":"Brokken","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1089\/thy.2006.16.1251","article-title":"Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients","volume":"16","author":"Chung","year":"2006","journal-title":"Thyroid."},{"key":"B14","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.1210\/jcem.86.10.7922","article-title":"Suppression of serum TSH by Graves' Ig: evidence for a functional pituitary TSH receptor","volume":"86","author":"Brokken","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"key":"B15","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1055\/s-0043-113831","article-title":"Hyperthyroidism in patients with Graves' ophthalmopathy, and thyroidal, skeletal and eye muscle specific type 2 deiodinase enzyme activities","volume":"125","author":"Molnar","year":"2017","journal-title":"Exp Clin Endocrinol Diab."},{"key":"B16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0002-9343(99)80137-5","article-title":"Pattern of recovery of the hypothalamic-pituitary-thyroid axis following radioactive iodine therapy in patients with Graves' disease","volume":"99","author":"Uy","year":"1995","journal-title":"Am J Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/BF03347070","article-title":"Relationship between thyroid stimulating hormone and thyroid stimulating immunoglobulin in Graves' hyperthyroidism","volume":"34","author":"Woeber","year":"2011","journal-title":"J Endocrinol Invest."},{"key":"B18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1210\/jcem.83.1.4492","article-title":"Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage","volume":"83","author":"Chiovato","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"key":"B19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1365-2265.1978.tb02217.x","article-title":"On the effect of thyrotropin and immunoglobulins related to Graves' disease on thyrotropin synthesis and secretion","volume":"9","author":"Dandona","year":"1978","journal-title":"Clin Endocrinol."},{"key":"B20","first-page":"569","article-title":"Usefulness and limitations of thyrotropin measurements as a first-line test for follow-up of Graves' patients","volume":"22","author":"Ng","year":"1993","journal-title":"Ann Acad Med Singapore."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00095\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T04:21:53Z","timestamp":1551414113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00095\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,1]]},"references-count":20,"alternative-id":["10.3389\/fendo.2019.00095"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2019.00095","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,1]]},"article-number":"95"}}